Form 4: Evolent Health Director Kim Keck Reports Acquisition of Restricted Stock Units

Director Kim Keck reports acquisition of restricted stock units in Evolent Health, Inc.

Summary

• On June 6, 2024, Kim Keck, a director of Evolent Health, Inc., acquired 7,709 shares of Class A Common Stock.
• These shares were granted as restricted stock units under the company's 2015 Omnibus Incentive Compensation Plan.
• The acquisition price was $0.
• Following the transaction, Ms. Keck beneficially owns 28,982 shares of Class A Common Stock.
• The restricted stock units vest on the earlier of June 6, 2025, and the date of the company's 2025 annual meeting, contingent upon continued service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of restricted stock units by a director is a common practice and generally viewed as a positive sign of alignment with company goals.

Positives

• The grant of restricted stock units to a director aligns their interests with the long-term performance of the company.
• Increased ownership by a director can be seen as a sign of confidence in the company's future prospects.

Future Outlook

The restricted stock units vest on the earlier of June 6, 2025, and the date of the company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects standard practices for aligning management incentives with shareholder value.

Stakeholder Impact

• Shareholders may view the increased ownership by a director as a positive signal.
• Employees may see this as a sign of confidence in the company's future.

Key Dates